In France, intractable Pain is managed by pain medicine & palliative cares. Intractable pain is severe, persistent pain that has not responded to standard treatment after a thorough evaluation by appropriate specialists, and that limits a person's daily function for at least three months. It is not a single disease but a clinical situation that can arise from cancer, failed back surgery, complex regional pain syndrome, peripheral neuropathy, central pain after stroke, or chronic pelvic and abdominal pain syndromes.
Intractable pain (ICD-10: G89 with appropriate fourth- and fifth-character extensions) is pain that persists despite reasonable attempts at standard medical treatment, is severe enough to substantially limit daily function for at least three months, and warrants escalated, often interventional or multidisciplinary management. The International Association for the Study of Pain (IASP) prefers the term 'refractory pain' and defines it as pain inadequately controlled by maximally tolerated doses of first- and second-line pharmacotherapy along with appropriate non-pharmacological care. The underlying mechanism may be nociceptive (tissue injury), neuropathic (nerve injury or disease), nociplastic (altered central pain processing without identifiable lesion), or mixed. Intractable pain is not synonymous with opioid-requiring pain — modern pain medicine prioritizes interventional, neuromodulation, rehabilitation, and behavioral approaches over high-dose opioids, which carry diminishing benefit and rising harm above 50-90 morphine milligram equivalents per day.
The key symptoms of Intractable Pain are: Constant or near-constant pain present for at least three months despite trials of two or more pharmacologic classes at adequate doses., Sleep disruption with frequent night-time awakening from pain, leading to chronic non-restorative sleep and daytime fatigue., Marked functional impairment: inability to work, perform activities of daily living, walk a typical distance, or perform self-care without rest., Pain that limits physical activity to less than 30 minutes at a time, often with significant deconditioning of muscles and joints., Mood symptoms — depression, anxiety, irritability, hopelessness — present in 50-65% of patients with intractable pain and worsen pain perception in a reciprocal cycle., Loss or restriction of social activities, hobbies, and intimate relationships from persistent pain and unpredictable flares., Cognitive symptoms ('pain fog'): difficulty concentrating, slowed processing speed, and short-term memory complaints..
Diagnosis of intractable pain is clinical and depends on a structured pain history, validated severity measurement, mechanism-based classification, and documented inadequate response to standard therapy. The history identifies onset, location, character (burning, electric, aching), pattern, aggravating and relieving factors, and prior treatments with doses and durations. Severity is measured with the Numeric Rating Scale (0-10), Visual Analog Scale, or Brief Pain Inventory; function is captured with the Oswestry Disability Index for back pain, Roland-Morris for low back pain, painDETECT for neuropathic features, and the PROMIS-29 for global function. Examination focuses on the affected region, neurological status, gait, joint range, and presence of allodynia or autonomic signs. Targeted investigations include MRI (preferred imaging for spine, brain, and joint pain when red flags are present), nerve conduction studies and electromyography for suspected neuropathy, quantitative sensory testing in specialized centers, and laboratory work to exclude reversible causes (HbA1c, vitamin B12, TSH, ESR, CRP, autoimmune panel where indicated). Psychological screening for depression, anxiety, PTSD, and substance use is standard. Diagnostic blocks (selective nerve root, medial branch, sympathetic) help identify pain generators for targeted intervention. Multidisciplinary intractable-pain evaluation typically involves a pain physician, a physical therapist, and a psychologist, and produces a documented treatment plan with realistic goals.
Outcomes depend on the underlying cause, duration of pain before specialist referral, comorbidities, and access to multidisciplinary care. With evidence-based multimodal therapy, approximately 30-50% of patients achieve clinically meaningful pain reduction (≥30% on the numeric rating scale) and 50-65% achieve meaningful function improvement at 12 months. Cancer-related intractable pain has better short-term response to escalation (interventional procedures, intrathecal pumps), with 70-85% achieving adequate control; long-term prognosis is dominated by the underlying cancer. Non-cancer intractable pain rarely resolves completely but typically stabilizes with appropriate care; function gains are often more durable than pain-score changes. Spinal cord stimulation provides 50% pain reduction in 50-60% of selected failed-back-surgery patients at 2 years. Multidisciplinary pain rehabilitation produces 30-50% function gains sustained at 12 months in two-thirds of completers. Prognostic factors for poor outcome include untreated depression, high pain catastrophizing, ongoing litigation or disability claims, comorbid substance use disorder, and very long pain duration before specialist care.
Pain medicine specialists, palliative care physicians, and interventional pain physicians have specific training in mechanism-based pain assessment, advanced pharmacotherapy, interventional procedures, and neuromodulation. Multidisciplinary clinics combining medicine, physical therapy, and behavioral health achieve substantially better outcomes than single-discipline care for intractable pain. Referral is appropriate when first-line pharmacotherapy and standard rehabilitation have failed after 8-12 weeks, when interventional procedures are being considered, or when comorbid depression, anxiety, or substance use complicate management.
Find specialists →Realistic expectations: noticeable improvement from optimized pharmacotherapy typically occurs over 4-12 weeks; from interventional procedures within hours to weeks depending on the procedure; from multidisciplinary rehabilitation programs over 4-8 weeks of intensive participation with continued home program. Spinal cord stimulation trials run 5-10 days before permanent implantation. Intrathecal pump titration takes 3-6 months. 'Recovery' for non-cancer intractable pain usually means sustainable pain control and restored function rather than pain elimination.
Graded exercise is one of the strongest evidence-based treatments for non-cancer intractable pain, with effect sizes comparable to many medications. Aim for 150 minutes per week of moderate aerobic activity (walking, swimming, cycling) plus two sessions of resistance training, starting at much lower volumes if currently inactive. Aquatic therapy reduces joint loading and is well tolerated. Avoid activities that produce sharp neuropathic flares; pace by time not pain. Supervised physical therapy is the most reliable way to establish a sustainable program.
Look for board certification in pain medicine (ABMS subspecialty after anesthesiology, neurology, physiatry, or psychiatry) or palliative care (HPM subspecialty). Ask whether the clinic offers interventional procedures, neuromodulation trials, and integrated behavioral health under one roof. For cancer pain, prioritize centers with combined pain medicine and palliative care expertise. Avoid clinics that rely primarily on escalating opioid doses without procedural and behavioral options.
Medically reviewed by AIHealz Medical Editorial Board · May 13, 2026
Ranked by patient outcomes and specialized experience.
Verifying top specialists in France.
Apply as specialist →Specialists who treat Intractable Pain. Get expert guidance and personalized care.